Literature DB >> 29242193

Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling.

Aruna Bitra1, Tzanko Doukov2, Jing Wang1, Gaelle Picarda1, Chris A Benedict1, Michael Croft1,3, Dirk M Zajonc1,4.   

Abstract

4-1BB (CD137) is a TNF receptor superfamily (TNFRSF) member that is thought to undergo receptor trimerization upon binding to its trimeric TNF superfamily ligand (4-1BBL) to stimulate immune responses. 4-1BB also can bind to the tandem repeat-type lectin galectin-9 (Gal-9), and signaling through mouse (m)4-1BB is reduced in galectin-9 (Gal-9)-deficient mice, suggesting a pivotal role of Gal-9 in m4-1BB activation. Here, using sulfur-SAD phasing, we determined the crystal structure of m4-1BB to 2.2-Å resolution. We found that similar to other TNFRSFs, m4-1BB has four cysteine-rich domains (CRDs). However, the organization of CRD1 and the orientation of CRD3 and CRD4 with respect to CRD2 in the m4-1BB structure distinctly differed from those of other TNFRSFs. Moreover, we mapped two Asn residues within CRD4 that are N-linked glycosylated and mediate m4-1BB binding to Gal-9. Kinetics studies of m4-1BB disclosed a very tight nanomolar binding affinity to m4-1BBL with an unexpectedly strong avidity effect. Both N- and C-terminal domains of Gal-9 bound m4-1BB, but with lower affinity compared with m4-1BBL. Although the TNF homology domain (THD) of human (h)4-1BBL forms non-covalent trimers, we found that m4-1BBL formed a covalent dimer via 2 cysteines absent in h4-1BBL. As multimerization and clustering is a prerequisite for TNFR intracellular signaling, and as m4-1BBL can only recruit two m4-1BB monomers, we hypothesize that m4-1BBL and Gal-9 act together to aid aggregation of m4-1BB monomers to efficiently initiate m4-1BB signaling.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  N-linked glycosylation; X-ray crystallography; cell surface receptor; galectin; protein structure; protein-protein interaction; recombinant protein expression; site-directed mutagenesis; surface plasmon resonance (SPR); tumor necrosis factor (TNF)

Mesh:

Substances:

Year:  2017        PMID: 29242193      PMCID: PMC5787808          DOI: 10.1074/jbc.M117.814905

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Modularity in the TNF-receptor family.

Authors:  J H Naismith; S R Sprang
Journal:  Trends Biochem Sci       Date:  1998-02       Impact factor: 13.807

2.  Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.

Authors:  N Mazurek; J C Byrd; Y Sun; M Hafley; K Ramirez; J Burks; R S Bresalier
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

3.  X-ray structures of human galectin-9 C-terminal domain in complexes with a biantennary oligosaccharide and sialyllactose.

Authors:  Hiromi Yoshida; Misa Teraoka; Nozomu Nishi; Shin-ichi Nakakita; Takanori Nakamura; Mitsuomi Hirashima; Shigehiro Kamitori
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

4.  S-SAD phasing study of death receptor 6 and its solution conformation revealed by SAXS.

Authors:  Heng Ru; Lixia Zhao; Wei Ding; Lianying Jiao; Neil Shaw; Wenguang Liang; Liguo Zhang; Li-Wei Hung; Naohiro Matsugaki; Soichi Wakatsuki; Zhi-Jie Liu
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-04-17

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 6.  The role of TNF superfamily members in T-cell function and diseases.

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

7.  The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding.

Authors:  Ivana Nemčovičová; Dirk M Zajonc
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-22

8.  Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function.

Authors:  Kausik Chattopadhyay; Udupi A Ramagopal; Arunika Mukhopadhaya; Vladimir N Malashkevich; Teresa P Dilorenzo; Michael Brenowitz; Stanley G Nathenson; Steven C Almo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-26       Impact factor: 11.205

9.  Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.

Authors:  Wendell Smith; Peter Tomasec; Rebecca Aicheler; Andrea Loewendorf; Ivana Nemčovičová; Eddie C Y Wang; Richard J Stanton; Matt Macauley; Paula Norris; Laure Willen; Eva Ruckova; Akio Nomoto; Pascal Schneider; Gabriele Hahn; Dirk M Zajonc; Carl F Ware; Gavin W G Wilkinson; Chris A Benedict
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

10.  Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions.

Authors:  Ivana Nemčovičová; Chris A Benedict; Dirk M Zajonc
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

View more
  18 in total

1.  An engineered 4-1BBL fusion protein with "activity on demand".

Authors:  Jacqueline Mock; Marco Stringhini; Alessandra Villa; Michael Weller; Tobias Weiss; Dario Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 11.205

2.  Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding.

Authors:  Aruna Bitra; Tzanko Doukov; Giuseppe Destito; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2018-12-13       Impact factor: 5.157

3.  Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor.

Authors:  Yuedi Wang; Yiyuan Gao; Congyi Niu; Bo Wang; Shushu Zhao; Gils Roex; Jiawen Qian; Jingbo Qie; Lin Chen; Chenhe Yi; Sébastien Anguille; Jie Liu; Feifei Luo; Yiwei Chu
Journal:  Cancer Immunol Immunother       Date:  2022-04-19       Impact factor: 6.630

4.  Crystal structure of the human 4-1BB/4-1BBL complex.

Authors:  Ryan N Gilbreth; Vaheh Y Oganesyan; Hamza Amdouni; Shabazz Novarra; Luba Grinberg; Arnita Barnes; Manuel Baca
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

5.  Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier.

Authors:  Aruna Bitra; Tzanko Doukov; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

Review 6.  Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation.

Authors:  Olivier Micheau
Journal:  Int J Mol Sci       Date:  2018-03-02       Impact factor: 5.923

7.  Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation.

Authors:  Chuan-Xia Zhang; Dai-Jia Huang; Valentin Baloche; Lin Zhang; Jing-Xiao Xu; Bo-Wen Li; Xin-Rui Zhao; Jia He; Hai-Qiang Mai; Qiu-Yan Chen; Xiao-Shi Zhang; Pierre Busson; Jun Cui; Jiang Li
Journal:  Oncogenesis       Date:  2020-07-06       Impact factor: 7.485

8.  Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab.

Authors:  S Michael Chin; Christopher R Kimberlin; Zygy Roe-Zurz; Pamela Zhang; Allison Xu; Sindy Liao-Chan; Debasish Sen; Andrew R Nager; Nicole Schirle Oakdale; Colleen Brown; Feng Wang; Yuting Yang; Kevin Lindquist; Yik Andy Yeung; Shahram Salek-Ardakani; Javier Chaparro-Riggers
Journal:  Nat Commun       Date:  2018-11-08       Impact factor: 14.919

Review 9.  Glycosylation of Immune Receptors in Cancer.

Authors:  Ruoxuan Sun; Alyssa Min Jung Kim; Seung-Oe Lim
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

10.  TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity.

Authors:  Xiaojie Yu; Sonya James; James H Felce; Blanka Kellermayer; David A Johnston; H T Claude Chan; Christine A Penfold; Jinny Kim; Tatyana Inzhelevskaya; C Ian Mockridge; Yasunori Watanabe; Max Crispin; Ruth R French; Patrick J Duriez; Leon R Douglas; Martin J Glennie; Mark S Cragg
Journal:  Commun Biol       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.